XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Stockholders' Equity | 6 Months Ended
--- | ---
Jul. 30, 2022
Equity [Abstract] |
Stockholders' Equity | Stockholders' Equity Share Repurchase Program During fiscal 2022, the Board of Directors terminated its previous 2012 $500 million share repurchase program (the “2012 Share Repurchase Program”) and authorized a new $200 million share repurchase program (the “2021 Share Repurchase Program”). On March 14, 2022, the Board of Directors expanded its repurchase authorization under the 2021 Share Repurchase Program by $100 million. Repurchases may be made on the open market or in privately negotiated transactions, pursuant to Rule 10b5-1 trading plans or other available means. There is no minimum or maximum number of shares to be repurchased under the program and the program may be discontinued at any time, without prior notice. On March 18, 2022, pursuant to existing share repurchase authorizations, the Company entered into an accelerated share repurchase agreement (the “2022 ASR Contract”) with a financial institution (the “2022 ASR Counterparty”) to repurchase an aggregate of $175.0 million of the Company’s common stock. Under the 2022 ASR Contract, the Company made a payment of $175.0 million to the 2022 ASR Counterparty and received an initial delivery of approximately 3.3 million shares of common stock on March 21, 2022. The Company received a final settlement of an additional 5.2 million shares under the 2022 ASR Contract on June 24, 2022. During the three and six months ended July 30, 2022, the Company repurchased 5,196,027 and 8,985,603 shares, respectively, of the Company’s common stock under the Company’s 2021 Share Repurchase Program at an aggregate cost of $105.0 million and $186.7 million, respectively, which is inclusive of the shares repurchased under the 2022 ASR Contract. There were no shares repurchased under the 2012 Share Repurchase Program during the three and six months ended July 31, 2021. As of July 30, 2022, the Company had remaining authority under the 2021 Share Repurchase Program to purchase $62.3 million of its common stock. Dividends The following sets forth the cash dividend declared per share:
| Three Months Ended |  | Six Months Ended
| Jul 30, 2022 |  | Jul 31, 2021 |  | Jul 30, 2022 |  | Jul 31, 2021
Cash dividend declared per share | $ | 0.2250 |  |  | $ | 0.1125 |  |  | $ | 0.4500 |  |  | $ | 0.2250 |
In accordance with the terms of the indenture governing the Notes, the Company has adjusted the conversion rate and the conversion price of the Notes for quarterly dividends exceeding $0.1125 per share. For each of the periods presented, dividends paid also included the impact from vesting of restricted stock units that are considered non-participating securities and are only entitled to dividend payments once the respective awards vest. Decisions on whether, when and in what amounts to continue making any future dividend distributions will remain at all times entirely at the discretion of the Company’s Board of Directors, which reserves the right to change or terminate the Company’s dividend practices at any time and for any reason without prior notice. The payment of cash dividends in the future will be based upon a number of business, legal and other considerations, including the Company’s cash flow from operations, capital expenditures, debt service and covenant requirements, cash paid for income taxes, earnings, share repurchases, economic conditions and U.S. and global liquidity. Accumulated Other Comprehensive Income (Loss) The changes in accumulated other comprehensive income (loss), net of related income taxes, are (in thousands):
| Foreign Currency Translation Adjustment |  | Derivative Financial Instruments Designated as Cash Flow Hedges |  |  | Defined Benefit Plans |  | Total
| Three Months Ended Jul 30, 2022
Balance at April 30, 2022 | $ | (153,301) |  |  | $ | 13,400 |  |  |  | $ | (6,812) |  |  | $ | (146,713) |
Gains (losses) arising during the period | (10,561) |  |  | 1,879 |  |  |  | (81) |  |  | (8,763) |
Reclassification to net earnings for gains realized | — |  |  | (1,039) |  |  |  | (9) |  |  | (1,048) |
Net other comprehensive income (loss) | (10,561) |  |  | 840 |  |  |  | (90) |  |  | (9,811) |
Balance at July 30, 2022 | $ | (163,862) |  |  | $ | 14,240 |  |  |  | $ | (6,902) |  |  | $ | (156,524) |
| Six Months Ended Jul 30, 2022
Balance at January 29, 2022 | $ | (135,861) |  |  | $ | 7,280 |  |  |  | $ | (6,968) |  |  | $ | (135,549) |
Gains (losses) arising during the period | (28,001) |  |  | 9,442 |  |  |  | 71 |  | (18,488) |
Reclassification to net earnings for gains realized | — |  |  | (2,482) |  |  |  | (5) |  |  | (2,487) |
Net other comprehensive income (loss) | (28,001) |  |  | 6,960 |  |  |  | 66 |  |  | (20,975) |
Balance at July 30, 2022 | $ | (163,862) |  |  | $ | 14,240 |  |  |  | $ | (6,902) |  |  | $ | (156,524) |
| Three Months Ended Jul 31, 2021
Balance at May 1, 2021 | $ | (108,403) |  |  | $ | (2,863) |  |  |  |  | $ | (9,636) |  |  | $ | (120,902) |
Gains (losses) arising during the period | (5,325) |  |  | 1,471 |  |  |  |  | (39) |  |  | (3,893) |
Reclassification to net earnings for losses realized | — |  |  | 790 |  |  |  |  | 77 |  |  | 867 |
Net other comprehensive income (loss) | (5,325) |  |  | 2,261 |  |  |  |  | 38 |  |  | (3,026) |
Balance at July 31, 2021 | $ | (113,728) |  |  | $ | (602) |  |  |  |  | $ | (9,598) |  |  | $ | (123,928) |
| Six Months Ended Jul 31, 2021
Balance at January 30, 2021 | $ | (105,970) |  |  | $ | (4,876) |  |  |  |  | $ | (9,829) |  |  | $ | (120,675) |
Gains (losses) arising during the period | (7,758) |  |  | 3,024 |  |  |  |  | 77 |  |  | (4,657) |
Reclassification to net earnings for losses realized | — |  |  | 1,250 |  |  |  |  | 154 |  |  | 1,404 |
Net other comprehensive income (loss) | (7,758) |  |  | 4,274 |  |  |  |  | 231 |  |  | (3,253) |
Balance at July 31, 2021 | $ | (113,728) |  |  | $ | (602) |  |  |  |  | $ | (9,598) |  |  | $ | (123,928) |
Details on reclassifications out of accumulated other comprehensive income (loss) to net earnings are (in thousands):
| Three Months Ended |  | Six Months Ended |  | Location of (Gain) Loss Reclassified from Accumulated OCI into Earnings
| Jul 30, 2022 |  | Jul 31, 2021 |  | Jul 30, 2022 |  | Jul 31, 2021 |
Derivative financial instruments designated as cash flow hedges: |  |  |  |  |  |  |  |  |
Foreign exchange currency contracts | $ | (1,198) |  |  | $ | 829 |  |  | $ | (2,872) |  |  | $ | 1,291 |  |  | Cost of product sales
Interest rate swap | 35 |  |  | 195 |  |  | 96 |  |  | 131 |  |  | Interest expense
Less income tax effect | 124 |  |  | (234) |  |  | 294 |  |  | (172) |  |  | Income tax expense
| (1,039) |  |  | 790 |  |  | (2,482) |  |  | 1,250 |  |  |
Defined benefit plans: |  |  |  |  |  |  |  |  |
Net actuarial loss amortization | 12 |  |  | 106 |  |  | 42 |  |  | 211 |  |  | Other expense
Prior service credit amortization | (22) |  |  | (17) |  |  | (45) |  |  | (34) |  |  | Other expense
Less income tax effect | 1 |  |  | (12) |  |  | (2) |  |  | (23) |  |  | Income tax expense
| (9) |  |  | 77 |  |  | (5) |  |  | 154 |  |  |
Total reclassifications during the period | $ | (1,048) |  |  | $ | 867 |  |  | $ | (2,487) |  |  | $ | 1,404 |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration